I

Investigators Research Group | Brownsburg, IN

Research site

(Unclaimed)

Location

321 East Northfield Drive Suite 100-200, Brownsburg, Indiana, United States of America

Site insights

Top conditions

Top treatments

Bococizumab

BMS-512148

Elinzanetant

Vibegron

BAY3427080

Dapagliflozin

Gabapentin

PF-05221304

Pimodivir

Oxybutynin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 28 total trials

A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (ACHIEVE-4)

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabete...

Active, not recruiting

Chronic Kidney Disease

Overweight

Drug: Orforglipron

Drug: Insulin Glargine

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabete...

Active, not recruiting

Type 2 Diabetes

Drug: LY3457263

Drug: Placebo

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects with Obesity Who Have Achieved At Least 15% Weight Loss on Tirzepatide (REMAIN-1)

Fractyl is evaluating Revita Duodenal Mucosal Resurfacing (DMR) in the REMAIN-1 pivotal study, which is designed to include two cohorts - an open lab...

Enrolling

Weight Change Trajectory

Obesity

Device: Sham

Device: Revita Duodenal Mucosal Resurfacing (DMR)

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain (ELARIS EM-COC)

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relati...

Enrolling

Endometriosis

Drug: Elagolix

Drug: Placebo